It’s been a mixed two weeks for small cap health companies, with 53 companies gaining ground, 64 losing it and 19 flatlining.
Here’s a table showing how ASX-listed healthcare stocks have been performing.
| Code | Name | Last | %Yr | %SixMth | %Mth | %Wk | Market Cap |
|---|---|---|---|---|---|---|---|
| RHY | Rhythm Biosciences | 1.61 | 651 | 44 | 23 | 33 | $ 331,992,128.79 |
| TRU | Truscreen | 0.079 | -1 | 39 | 25 | $ 29,029,300.24 | |
| VLS | Vita Life Sciences.. | 1.95 | 112 | 65 | 58 | 23 | $ 103,199,119.52 |
| ACW | Actinogen Medical | 0.135 | 514 | 133 | 8 | 23 | $ 234,144,196.58 |
| DVL | Dorsavi Ltd | 0.022 | -44 | -37 | 5 | 22 | $ 7,028,651.44 |
| AC8 | Auscann Grp Hlgs Ltd | 0.105 | -25 | -19 | 14 | 18 | $ 46,257,446.55 |
| SOM | SomnoMed Limited | 2.6 | 19 | 34 | 11 | 17 | $ 216,829,405.30 |
| NTI | Neurotech Intl | 0.057 | 128 | -10 | 30 | 16 | $ 38,325,051.93 |
| MDR | Medadvisor Limited | 0.365 | -6 | -3 | 18 | 16 | $ 143,440,648.96 |
| OSP | Osprey Med Inc | 1.03 | -53 | -43 | 18 | 15 | $ 25,530,249.29 |
| EPN | Epsilon Healthcare | 0.155 | -35 | -18 | 19 | 15 | $ 26,978,972.86 |
| PTX | Prescient Ltd | 0.275 | 358 | 184 | -5 | 15 | $ 174,039,493.86 |
| JTL | Jayex Technology Ltd | 0.026 | -32 | -42 | 4 | 13 | $ 6,230,713.48 |
| MEM | Memphasys Ltd | 0.067 | -42 | -4 | -3 | 12 | $ 52,283,770.24 |
| PAL | Palla Pharma Ltd | 0.355 | -48 | -21 | 37 | 11 | $ 56,669,607.05 |
| OSL | Oncosil Medical | 0.052 | -61 | -47 | 13 | 11 | $ 41,201,851.29 |
| NYR | Nyrada Inc. | 0.26 | 18 | -16 | 2 | 11 | $ 31,954,740.22 |
| ANP | Antisense Therapeut. | 0.305 | 144 | 45 | 49 | 9 | $ 180,960,048.05 |
| GLH | Global Health Ltd | 0.37 | -10 | -29 | -6 | 7 | $ 20,945,475.04 |
| NC6 | Nanollose Limited | 0.089 | 27 | -19 | -2 | 7 | $ 13,381,773.12 |
| BXN | Bioxyne Ltd | 0.03 | 100 | 50 | 25 | 7 | $ 19,204,361.94 |
| TSN | The Sust Nutri Grp | 0.3 | 71 | -29 | -6 | 7 | $ 26,218,723.95 |
| MDC | Medlab Clinical Ltd | 0.165 | -15 | -18 | 6 | 6 | $ 56,458,985.72 |
| CDY | Cellmid Limited | 0.066 | -32 | -3 | 25 | 6 | $ 12,370,416.96 |
| CYC | Cyclopharm Limited | 1.965 | -2 | -24 | 16 | 6 | $ 183,014,653.08 |
| EXL | Elixinol Wellness | 0.095 | -37 | -47 | -10 | 6 | $ 30,643,384.07 |
| RCE | Recce Pharmaceutical | 0.955 | -6 | -12 | -1 | 6 | $ 170,312,090.06 |
| SHG | Singular Health | 0.21 | -51 | -16 | 5 | $ 14,232,566.04 | |
| IRX | Inhalerx Limited | 0.105 | 80 | 0 | 30 | 5 | $ 16,846,695.70 |
| IMU | Imugene Limited | 0.47 | 710 | 147 | -2 | 4 | $ 2,677,009,653.10 |
| ACR | Acrux Limited | 0.12 | -33 | -20 | 0 | 4 | $ 34,041,640.56 |
| CDX | Cardiex Limited | 0.073 | 55 | 7 | 20 | 4 | $ 68,387,568.26 |
| ALC | Alcidion Group Ltd | 0.365 | 204 | -10 | -1 | 4 | $ 382,545,203.98 |
| IMM | Immutep Ltd | 0.61 | 135 | 44 | 14 | 4 | $ 533,670,500.63 |
| ADO | Anteotech Ltd | 0.255 | 122 | -39 | -4 | 4 | $ 492,972,929.00 |
| TLX | Telix Pharmaceutical | 6.03 | 256 | 59 | 0 | 4 | $ 1,753,198,384.20 |
| AGH | Althea Group | 0.3 | -36 | -35 | 25 | 3 | $ 90,484,000.38 |
| IHL | Incannex Healthcare | 0.37 | 335 | 40 | -1 | 3 | $ 459,240,641.14 |
| MVF | Monash IVF Group Ltd | 0.955 | 61 | 6 | -2 | 3 | $ 374,049,446.40 |
| ARX | Aroa Biosurgery | 1.18 | -16 | 1 | 11 | 3 | $ 394,851,552.48 |
| RAC | Race Oncology Ltd | 3.23 | 192 | -1 | -8 | 2 | $ 483,597,780.60 |
| CPH | Creso Pharma Ltd | 0.1175 | 320 | -38 | 7 | 2 | $ 138,405,885.26 |
| CGS | Cogstate Ltd | 2.4 | 147 | 167 | -2 | 2 | $ 377,997,644.16 |
| IMC | Immuron Limited | 0.13 | -54 | -30 | -7 | 2 | $ 28,405,824.50 |
| NOX | Noxopharm Limited | 0.54 | 10 | -14 | -7 | 2 | $ 154,886,113.50 |
| DXB | Dimerix Ltd | 0.275 | 2 | 8 | -11 | 2 | $ 89,844,626.48 |
| HCT | Holista CollTech Ltd | 0.059 | -39 | 18 | -6 | 2 | $ 15,970,247.05 |
| MX1 | Micro-X Limited | 0.31 | 55 | -2 | -5 | 2 | $ 140,338,962.23 |
| ONT | 1300 Smiles Limited | 8.15 | 23 | 11 | 1 | 2 | $ 192,978,829.60 |
| LDX | Lumos Diagnostics | 0.945 | -2 | 2 | $ 142,644,792.35 | ||
| PSQ | Pacific Smiles Grp | 2.9 | 50 | 3 | 11 | 1 | $ 454,808,523.30 |
| JHC | Japara Healthcare Lt | 1.4 | 250 | 71 | 1 | 1 | $ 379,509,698.40 |
| PAA | Pharmaust Limited | 0.1 | -23 | 6 | 18 | 1 | $ 30,423,588.77 |
| OPT | Opthea Limited | 1.285 | -46 | -12 | -6 | 0 | $ 447,648,742.58 |
| ZLD | Zelira Therapeutics | 0.039 | -51 | -35 | -9 | 0 | $ 47,612,918.64 |
| SCU | Stemcell United Ltd | 0.014 | -18 | -30 | 0 | 0 | $ 14,606,489.21 |
| PYC | PYC Therapeutics | 0.145 | -15 | -15 | 4 | 0 | $ 461,234,284.94 |
| PXS | Pharmaxis Ltd | 0.12 | 35 | 43 | -4 | 0 | $ 52,256,070.61 |
| PGC | Paragon Care Limited | 0.305 | 56 | 36 | -8 | 0 | $ 108,934,216.69 |
| OVN | Oventus Medical Ltd | 0.115 | -50 | -39 | -23 | 0 | $ 30,215,816.88 |
| MEB | Medibio Limited | 0.008 | -27 | 0 | 0 | 0 | $ 14,360,491.98 |
| IVX | Invion Ltd | 0.013 | 18 | 63 | 0 | 0 | $ 76,242,518.08 |
| ICS | ICSGlobal Limited | 0.575313 | 30 | 5 | 0 | 0 | $ 6,054,604.94 |
| HXL | Hexima | 0.365 | 20 | 109 | -4 | 0 | $ 45,235,123.79 |
| FFC | Farmaforce Ltd | 0.051 | -27 | -46 | 0 | 0 | $ 6,664,729.98 |
| CHM | Chimeric Therapeutic | 0.31 | 9 | -7 | 0 | $ 67,647,317.12 | |
| BPH | BPH Energy Ltd | 0.059 | 18 | -33 | -5 | 0 | $ 39,230,243.95 |
| BD1 | Bard1 Life Sciences | 1.06 | 31 | -66 | -8 | 0 | $ 98,370,364.40 |
| ATX | Amplia Therapeutics | 0.2 | -23 | -22 | -5 | 0 | $ 24,964,268.00 |
| AHK | Ark Mines Limited | 0.034 | 0 | 0 | 0 | 0 | $ 1,778,919.95 |
| ADR | Adherium Ltd | 0.014 | -39 | -13 | -18 | 0 | $ 29,795,467.13 |
| PNV | Polynovo Limited | 1.86 | -26 | -39 | -5 | 0 | $ 1,269,865,044.48 |
| BOT | Botanix Pharma Ltd | 0.0645 | -36 | -25 | -8 | -1 | $ 61,307,950.66 |
| OCC | Orthocell Limited | 0.535 | 45 | 6 | 5 | -1 | $ 100,843,636.95 |
| NXS | Next Science Limited | 1.275 | 9 | -22 | -4 | -1 | $ 244,497,777.62 |
| 1AD | Adalta Limited | 0.083 | -34 | -46 | -14 | -1 | $ 22,556,521.18 |
| CMP | Compumedics Limited | 0.38 | -14 | -16 | -7 | -1 | $ 67,321,920.24 |
| CAJ | Capitol Health | 0.36 | 44 | -3 | -4 | -1 | $ 377,938,341.88 |
| SDI | SDI Limited | 1.01 | 21 | 23 | 1 | -1 | $ 120,054,185.30 |
| ILA | Island Pharma | 0.32 | -32 | -3 | -2 | $ 13,741,813.12 | |
| RNO | Rhinomed Ltd | 0.31 | 88 | 158 | -14 | -2 | $ 78,680,830.92 |
| ALA | Arovella Therapeutic | 0.048 | 17 | 17 | 0 | -2 | $ 23,079,359.33 |
| VTI | Vision Tech Inc | 0.95 | -72 | -37 | -10 | -2 | $ 23,044,612.50 |
| PAR | Paradigm Bio. | 1.87 | -32 | -22 | -11 | -2 | $ 438,552,218.97 |
| PBP | Probiotec Limited | 2.15 | 24 | 7 | 1 | -2 | $ 168,696,322.90 |
| EYE | Nova EYE Medical Ltd | 0.4 | 21 | 25 | 1 | -2 | $ 58,221,516.40 |
| VHT | Volpara Health Tech | 1.23 | -16 | -5 | 2 | -3 | $ 316,704,882.06 |
| PIQ | Proteomics Int Lab | 0.875 | 55 | -26 | -8 | -3 | $ 92,098,890.63 |
| MVP | Medical Developments | 4.85 | -11 | -15 | -7 | -3 | $ 348,484,246.08 |
| DOC | Doctor Care Anywhere | 0.68 | -34 | -8 | -3 | $ 129,340,377.16 | |
| 4DX | 4Dmedical Limited | 1.31 | -39 | -18 | -11 | -3 | $ 280,000,722.42 |
| ICR | Intelicare Holdings | 0.097 | -67 | -66 | -1 | -3 | $ 4,665,761.21 |
| ATH | Alterity Therap Ltd | 0.03 | -19 | -9 | -2 | -3 | $ 69,799,362.76 |
| GSS | Genetic Signatures | 1.45 | -28 | 2 | -4 | -3 | $ 209,548,100.39 |
| AHC | Austco Healthcare | 0.145 | 51 | 56 | -3 | -3 | $ 41,207,397.90 |
| BWX | BWX Limited | 4.62 | 9 | -4 | -6 | -3 | $ 749,738,653.18 |
| IDT | IDT Australia Ltd | 0.57 | 245 | 46 | -14 | -3 | $ 137,919,597.75 |
| TD1 | Tali Digital Limited | 0.028 | -7 | -45 | -10 | -3 | $ 27,025,267.88 |
| CU6 | Clarity Pharma | 1.09 | -13 | -4 | $ 186,960,286.53 | ||
| NEU | Neuren Pharmaceut. | 1.8 | 67 | 41 | -14 | -4 | $ 239,334,784.40 |
| NSB | Neuroscientific | 0.385 | 22 | 35 | -23 | -4 | $ 54,519,224.34 |
| MXC | Mgc Pharmaceuticals | 0.05 | 127 | -17 | -14 | -4 | $ 120,204,792.75 |
| BIT | Biotron Limited | 0.05 | -44 | -18 | -9 | -4 | $ 35,096,635.65 |
| EZZ | EZZ Life Science | 0.49 | -22 | -4 | -4 | $ 6,120,000.00 | |
| MMJ | MMJ Group Hlds Ltd | 0.07 | -36 | -33 | -13 | -4 | $ 16,096,778.95 |
| ZNO | Zoono Group Ltd | 0.45 | -69 | -49 | 13 | -4 | $ 75,217,281.69 |
| UBI | Universal Biosensors | 0.735 | 133 | -2 | -13 | -5 | $ 132,407,123.09 |
| PAB | Patrys Limited | 0.042 | 76 | 62 | 0 | -5 | $ 76,801,842.60 |
| CAN | Cann Group Ltd | 0.3 | -20 | -41 | 5 | -5 | $ 104,656,350.90 |
| CYP | Cynata Therapeutics | 0.595 | -27 | 1 | 13 | -5 | $ 89,547,871.25 |
| CBL | Control Bionics | 0.555 | -26 | -13 | -5 | $ 28,688,616.42 | |
| KZA | Kazia Therapeutics | 1.46 | 83 | 5 | -8 | -5 | $ 197,502,791.41 |
| IBX | Imagion Biosys Ltd | 0.069 | -10 | -52 | -8 | -5 | $ 72,470,561.59 |
| CTE | Cryosite Limited | 0.34 | 36 | 26 | -16 | -6 | $ 16,595,251.42 |
| AVE | Avecho Biotech Ltd | 0.017 | 55 | -15 | -6 | -6 | $ 33,050,097.47 |
| IPD | Impedimed Limited | 0.165 | 99 | 32 | 57 | -6 | $ 254,507,293.76 |
| RSH | Respiri Limited | 0.065 | -64 | -43 | -12 | -6 | $ 47,707,492.14 |
| BDX | Bcaldiagnostics | 0.16 | -9 | -6 | $ 21,044,249.92 | ||
| 1ST | 1St Group Ltd | 0.016 | -50 | -28 | 0 | -6 | $ 8,060,414.83 |
| S66 | Star Combo | 0.295 | -14 | 9 | -6 | -6 | $ 39,740,178.36 |
| OIL | Optiscan Imaging | 0.22 | 120 | -52 | -8 | -6 | $ 132,909,904.43 |
| RGS | Regeneus Ltd | 0.073 | -46 | -42 | -4 | -6 | $ 22,369,894.72 |
| GTG | Genetic Technologies | 0.007 | -13 | -13 | 0 | -7 | $ 55,356,540.86 |
| M7T | Mach7 Tech Limited | 0.94 | -4 | -24 | -6 | -7 | $ 228,981,038.25 |
| RAP | Resapp Health Ltd | 0.063 | -43 | 15 | -16 | -7 | $ 55,847,810.01 |
| OSX | Osteopore Limited | 0.25 | -51 | -49 | -15 | -7 | $ 30,489,741.88 |
| PCK | Painchek Ltd | 0.049 | -48 | -26 | 2 | -8 | $ 55,458,435.15 |
| RHT | Resonance Health | 0.11 | -33 | -44 | 10 | -8 | $ 52,997,977.82 |
| LBT | LBT Innovations | 0.105 | -13 | 17 | -25 | -9 | $ 30,357,092.22 |
| AT1 | Atomo Diagnostics | 0.3075 | -1 | 43 | 6 | -10 | $ 130,780,907.84 |
| VBS | Vectus Biosystems | 1.8 | 84 | 89 | 20 | -10 | $ 57,366,905.40 |
| ONE | Oneview Healthcare | 0.38 | 743 | 1 | -6 | -12 | $ 164,716,796.14 |
| AMT | Allegra Orthopaedics | 0.205 | 24 | -38 | -16 | -13 | $ 21,414,136.62 |
| BNO | Bionomics Limited | 0.13 | 13 | -48 | -30 | -13 | $ 136,295,560.44 |
| LCT | Living Cell Tech. | 0.008 | -43 | -38 | -20 | -20 | $ 6,424,661.03 |
| ALT | Analytica Limited | 0.002 | -33 | -50 | 0 | -20 | $ 6,920,701.69 |
Rhythm Biosciences (ASX:RHY) was the biggest winner, up 33% after it shared an investors’ presentation deck this week which highlighted the imminent commercialisation of ColoSTAT, a technology that could detect the presence of protein markers in patients with colorectal cancer.
Tests have demonstrated a 33% higher accuracy than the current standard Faecal Immunochemical Test (FIT) used.
The company will soon make a submission to the Therapeutic Goods Administration (TGA), and is on track to receive the European CE mark by the end of the year.
Next cab off the ranks, up 25%, was cervical cancer screening company Truscreen (ASX:TRU) on last week’s news that its TruScreen device is now equipped with an improved cyber security upgrade, while flagging expanded distribution opportunities in China.
Vita Life Sciences (ASX:VLS) was up 24% on no news, and Actinogen Medical (ASX:ACW) was also up 23% after it released its September quarterly detailing the advance of the Xanamem clinical development pipeline and the filing of an Investigational New Drug submission to the US FDA for its FXS program.
And Dorsavi (ASX:DVL) was up 22% off the back of its quarterly reporting a 54% increase in revenue to $585,000 from the previous corresponding period.
The company believes that Q2 FY21 has a promising outlook with additional workers returning to the workplace and improved US site access.
Who flatlined?
Flat despite being granted a Chinese patent covering OPT-302 was Opthea Limited (ASX:OPT), and Zelira Therapeutics (ASX:ZLD) which raised US$5 million from a US fund.
Also flat was Pharmaxis (ASX:PXS) which does the first patient in its Phase 2 bone marrow cancer trial and Chimeric Therampeutics (ASX:CHM) which successfully completed manufacturing for CHM 2101 research grade plasmids – a critical first step in the development of CDH17 CAR T.
Who’s the biggest loser?
The biggest loser was a tie between Living Cell Tec (ASX:LCT) which dropped 20% despite signing a non-binding MOU with New Zealand biotechnology company NZeno for it to breed and maintain pigs to provide tissue for the upcoming third clinical trial of NTCELL in Parkinson’s disease – and Analytica Limited (ASX:ALT) which dropped 20% on no news.